Related Experiment Video
Updated: May 19, 2026
04:04
Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
Published on: July 11, 2025
Taurine and central nervous system disorders
Janet Menzie1, Chunliu Pan, Howard Prentice
1Program in Integrative Biology, Florida Atlantic University, Boca Raton, FL, 33431, USA, jmenzie@fau.edu.
Amino Acids
|August 21, 2012
Summary
Taurine, an endogenous amino acid, offers multifaceted therapeutic potential for neurological disorders. This review explores its action and clinical applications for Alzheimer's, Parkinson's, and Huntington's diseases.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Neurological disorders involve complex pathophysiological pathways leading to neuronal dysfunction.
- Multifaceted therapeutic interventions are sought to address these complex mechanisms.
- Taurine is an endogenous amino acid with diverse physiological roles in the central nervous system.
Purpose of the Study:
- To review the mode of action of taurine.
- To explore the clinical applications of taurine in neurodegenerative diseases.
- To highlight taurine as a potential therapeutic agent for neurological conditions.
Main Methods:
- Literature review of taurine's physiological functions.
- Analysis of taurine's mechanism of action in the central nervous system.
- Examination of existing clinical data and research on taurine for neurological diseases.
Main Results:
- Taurine demonstrates significant neuroprotective and neuromodulatory effects.
- Its multifaceted action addresses various pathological aspects of neurodegeneration.
- Evidence suggests potential benefits in Alzheimer's, Parkinson's, and Huntington's disease models.
Conclusions:
- Taurine presents a promising therapeutic candidate for neurological disorders due to its broad physiological functions.
- Further clinical investigation is warranted to fully establish its efficacy in treating Alzheimer's, Parkinson's, and Huntington's disease.
- Taurine's endogenous nature and multifaceted action make it an attractive target for future drug development in neurodegenerative diseases.
Related Concept Videos
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:31Neurotransmitters
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.